Major Program
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
University of Rochester NCORP Research Base
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT05364086
This study compares treatment outcomes between patients of African American/Black (AA) ancestry and European American/White (EA) ancestry currently receiving immune checkpoint inhibitor treatment. Collecting samples of blood, saliva, stool, and health and treatment information from racially diverse patients receiving immune checkpoint inhibitor treatment over time may help doctors better understand healthcare disparities among all cancer patients.
Condition
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Investigators
Charles S Kamen, PhD, Song Yao, PhD, Jay W. Carlson, Bryan A. Faller, Site Public Contact